Featured
Finding Balance in the Noise
"Almost a third of over-65s will fall each year", but could nGVS represent a discreet tool against imbalance?
Supported by
Finding Balance in the Noise
"Almost a third of over-65s will fall each year", but could nGVS represent a discreet tool against imbalance?
Sick Enough: The Silent Struggles of Sub-clinical Illness in Modern Medicine
To live in the grey zone of sub-clinical pathology is to be unwell enough to hurt, but not enough to be heard.
In the Company of Shadows: Love, Labour, and the Long Way Through
First-generation medical students carry two textbooks - one devoted to anatomy, the other towards cultivating resilience.
Gut Feelings: Harnessing the Gut Microbiome to Manage Anxiety in Primary Care
Trillions of microbes inside us are not mere bystanders, but quiet architects of our moods.
ThredUp: Scaling Second-Hand for a Sustainable Future
"Second-hand in the U.S., and globally, is projected to nearly double by 2030. The short answer is that the world needs more resale,” ThredUp's James Reinhart reveals how partnerships, tech, and trust are fueling the recommerce boom.
From Strengthening Fleets to Smart Ships: Navigating Tanker Cycles with Ardmore
"Anybody can be a shipowner if they can raise the capital. What sets you apart is the organization you build around the ships,” Gernot Ruppelt highlights why culture and execution matter as much as fleet size in today’s tanker trade.
Electricity Designed for the Future: EDF power solutions’ Tristan Grimbert on Competing in North America’s Toughest Energy Market
"We call it the post-COVID storm. Inflation, tariffs, interconnection delays - it’s never been harder to deliver fixed-price projects with long lifecycles,” Tristan Grimbert explains how EDF power solutions is navigating today’s volatile energy economics.
PowerTrack and Stem, Inc.’s Push for Renewable Confidence
"The CEO’s role isn’t operational - it’s to set the long-term vision and take the risk buffer so others can take the micro bets that are needed to help grow the business,” Arun Narayanan explains why long-term thinking is essential to scaling sustainable energy.
Not Just Net Zero: Why B Corp™ Must Lead the Charge on Equity and Emissions
"The beating heart and soul of this movement are smaller- and medium-sized enterprises,” Kylie Nealis explains how B Lab™ is raising the bar for business standards in climate justice.
How AI, Carbon Markets, and Co-Ops Are Changing the Economics of Farming
"Changing the mindset from ‘more fertilizer equals more grain’ to ‘resilient soils equals profitability’ takes proof,” Arva Intelligence's Jay McEntire underlines how farmers themselves are the real heroes of regenerative agriculture.
Feeding the Future: Inside Aurélio Pavinato’s Big Dream for Agriculture
"Our dream is to positively impact upon future generations, by being the leader in global efficiency in the agricultural sector, and, above all, to respect the planet,” Dr. Aurélio Pavinato outlines why soil health and circularity are central to SLC Agrícola's long-term growth.
From Pistons to Powertrains: The Road Ahead for Shriram Pistons & Rings
"Compressed natural gas requires a complete redesign of the pistons, the rings, and the engine valves - it’s not just a drop-in fuel,” Krishnakumar Srinivasan shows how SPR is future-proofing technology for CNG, ethanol, hybrids and EVs.
Built to Last: Why Acme Brick’s Ed Watson Believes Durability Is the Ultimate Sustainability
"If I were choosing a material for my home or business, I’d look at something that could last a century,” Ed Watson discusses Acme Brick’s future strategy: diversifying beyond brick, while preserving its legacy roots.
Garbage into Gains: How RoadRunner is Using AI To Modernize Waste
"We know exactly how many containers are out there, how full they are and what’s in them, every day. That level of insight is mind-blowing,” Graham Rihn explains why precision data is reshaping the business of waste.
Onyx @ Union Square: Shankar Musunuri, Ocugen
What if the key to curing blindness wasn't targeting individual genes, but entire genetic networks?
Onyx @ Union Square: Mike Exton, Lexicon Pharmaceuticals
Lexicon's latest drug for obesity and weight management has a novel mechanism and is backed by Novo Nordisk.
The future of fluorescence is smaller, smarter, and more accessible
FLIM LABS is redesigning the tools of fluorescence-lifetime imaging to enable broader access across medicine, pharma, and environmental science.
Onyx Studio Sessions: Paula Brown Stafford, Allucent
Allucent is a CRO which has overseen many therapeutics through to FDA approval.
Onyx @ Union Square: Colleen Cutcliffe, Pendulum
Ever thought a probiotic could help manage blood sugar by stimulating GLP-1?
How Piramal Pharma plans to become a multi-billion dollar business
Peter DeYoung lends insights on the strategic approach behind Piramal Phama’s expansion and growth.
We all want our hospital records in one place. Is Novellia the app to do it?
Shashi Shankar explains how his app unifies patients' scattered medical records all together, and what that has to do with the 21st Century Cures Act.
Adil's JPM Week VLOG
Join me in San Fran as I interview CEOs and reveal what Onyx has in store for readers this year.
Onyx Studio Sessions: Fabian Gerlinghaus, Cellares
Can Cellares bring down the cost of some of the most expensive new therapies on the market?
Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves
"Think of us as a critical partner in the ecosystem, ensuring that brilliant innovation doesn’t get stuck in the development phase but actually reaches the patients who need them."
Onyx @ Union Square: Shankar Musunuri, Ocugen
What if the key to curing blindness wasn't targeting individual genes, but entire genetic networks?
Onyx @ Union Square: Mike Exton, Lexicon Pharmaceuticals
Lexicon's latest drug for obesity and weight management has a novel mechanism and is backed by Novo Nordisk.
Onyx Studio Sessions: Paula Brown Stafford, Allucent
Allucent is a CRO which has overseen many therapeutics through to FDA approval.